🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a non-comparative open-label multicenter Phase 2 clinical trial com...
Status
Completed
Location
University of California San Francisco
Start Date
2017-05-17
Trial ID
NCT03007732
The investigators evaluated whether it was possible to improve the measurem...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00927576
The purpose of this 16-week research study is to determine whether a drug c...
Status
Completed
Location
The Children's Hospital
Start Date
2008-07
Trial ID
NCT01112683
Neurobiological and neuropsychological approaches to investigate the potent...
Status
Completed
Location
Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
Start Date
2020-04-01
Trial ID
NCT04057534
Targeted Muscle Reinnervation increases the control signals available for c...
Status
Completed
Location
Rehabilitation Institute of Chicago
Start Date
2013-06
Trial ID
NCT03097978
Treatments Being Tested
Negative symptoms are an important factor in preventing patients from retur...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2020-02
Trial ID
NCT04254965
Treatments Being Tested
The Brain Ketone Body Challenge Imaging Study will measure how the brain us...
Status
Withdrawn
Location
Wake Forest School of Medicine
Start Date
2016-08-08
Trial ID
NCT03204604
This international, multi-center, double-blind, randomized, controlled clin...
Status
Completed
Location
Shirley Ryan Ability Lab
Start Date
2017-05-08
Trial ID
NCT03112928
Treatments Being Tested
Presence/absence in bed along with heartbeat, respiration, and gross motion...
Status
Terminated
Location
Budd Terrace
Start Date
2012-12
Trial ID
NCT01774708
Treatments Being Tested
This is a multicenter, randomized controlled, open-label Phase II clinical ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-26
Trial ID
NCT07406724